It is a good day for Tesla [NASDAQ: TSLA] and Apple [NASDAQ:AAPL] investors. The two companies have done a stock split to become accessible to a wider investor base. Investor momentum in the two is being driven by the excitement around the stock split and the fact that they are both fundamentally strong companies. Tesla […]
Which One is Better After Stock Split: TSLA or AAPL? Read More »
Tech stocks have been on fire lately. It appears that they continue hitting new record-breaking highs, for quite a while. Software is everywhere & considered to be the focal point of business innovation lately. The software industry made progress rapidly. The primary mode of software deployment has moved from legacy on-premise to cloud architecture with
Here’s 10 Trending Stocks in Software – Infrastructure Industry Read More »
The markets are upbeat this morning with the S&P 500, the Dow and the NASDAQ all in the green. This comes amidst analysts’ projections that the uncertainty that characterized the market since March is easing up. When the COVID-19 lockdowns started, the markets entered into deep uncertainty with corporations suspending their projections for future earnings.
Stocks to watch as Market Sentiment Turns Positive Amidst a Drop in Uncertainty Read More »
Aimmune Therapeutics, Inc. [NASDAQ: AIMT] disclosed today it has signed a definitive agreement with a wholly-owned subsidiary of Nestle S.A, Sociétés des Produits Nestlé S.A. Sociétés des Produits Nestlé S.A to purchase Aimmune for $34.50 per share in an all-cash transaction representing the total equity value of $2.6 billion, as per the agreement. All the
Aimmune Therapeutics [NASDAQ: AIMT] Signs Definitive Agreement With Nestle Read More »
FSD Pharma Inc. [NASDAQ: HUGE] has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to gain approval for the use of FSD201 to treat COVID-19 patients, the company disclosed today. FSD201 has anti-inflammatory properties that are proven to be useful to avoid cytokines storm linked with acute lung
FSD Pharma [NASDAQ: HUGE] Decides To File IND For FSD201 To Treat COVID-19 Patients Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.